A Prospective Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer with Arterial Involvement
Naoki Ikenaga, Yoshihiro Miyasaka, Takao Ohtsuka, Kohei Nakata, Tomohiko Adachi, Susumu Eguchi, Kazuyoshi Nishihara, Masafumi Inomata, Hiroshi Kurahara, Toru Hisaka, Hideo Baba, Hiroaki Nagano, Toshiharu Ueki, Hirokazu Noshirο, Shoji Tokunaga, Kousei Ishigami, Masafumi Nakamura, for the Kyushu Study Group of Treatment for Pancreatobiliary Cancer
Topics & Concepts
MedicineGemcitabineSurgical oncologyPancreatic cancerNeoadjuvant therapyClinical endpointConfidence intervalChemotherapyMulticenter trialProspective cohort studyOncologyMulticenter studyInternal medicineSurgeryClinical trialCancerRandomized controlled trialBreast cancerPancreatic and Hepatic Oncology ResearchPancreatitis Pathology and TreatmentEsophageal Cancer Research and Treatment